texas oncology more breakthroughs. more victories
Request an Appointment


Lung cancer care is becoming increasingly personalized with tailored treatments targeting the unique cellular characteristics of tumors. To support this, Texas Onocology is pleased to announce our participation in the MYLUNG Study, an observational/interventional research trial to improve clinically-appropriate utilization of molecular testing and treatment assignment for non-small lung cancer (NSCLC). MYLUNG brings together diverse organizations across the spectrum of drug development, therapy, and care to observe up to 12,000 NSCLC patients over a five-year period. Talk to your care team if you’re interested in participating in this study and helping us advance hope for the future.

These locations are participating in the research: